Polycystin-1 Inhibits Cell Proliferation through Phosphatase PP2A/B56.

Biomed Res Int

Membrane Protein Disease Research Group, Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton T6G 2H7, Canada.

Published: March 2020

Autosomal dominant polycystic kidney disease (ADPKD) is associated with a number of cellular defects such as hyperproliferation, apoptosis, and dedifferentiation. Mutations in polycystin-1 (PC1) account for ∼85% of ADPKD. Here, we showed that wild-type (WT) or mutant PC1 composed of the last five transmembrane (TM) domains and the C-terminus (termed PC1-5TMC) inhibits cell proliferation and protein translation, as well as the downstream effectors of mTOR, consistent with previous reports. Knockdown of B56, a subunit of the protein phosphatase 2A (PP2A) complex, or application of PP2A inhibitor okadaic acid or calyculin A, abolished the inhibitory effect of PC1 and PC1-5TMC on proliferation, indicating that PP2A/B56 mediates the regulation of cell proliferation by PC1. In addition to the phosphorylated S6 and 4EBP1, B56 was also downregulated by PC1 and PC1-5TMC. Furthermore, the downregulation of B56, which may be mediated by mTOR but not AKT, can account for the dependence of PC1-inhibited proliferation on PP2A.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770331PMC
http://dx.doi.org/10.1155/2019/2582401DOI Listing

Publication Analysis

Top Keywords

cell proliferation
12
inhibits cell
8
pc1 pc1-5tmc
8
proliferation
5
pc1
5
polycystin-1 inhibits
4
proliferation phosphatase
4
phosphatase pp2a/b56
4
pp2a/b56 autosomal
4
autosomal dominant
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!